Big Pharma companies sue CalPERS to block disclosure of drug prices
The Sacramento Bee reported on 2/22/19 that "CalPERS could be on the hook for attorneys’ fees after a Los Angeles County judge ruled that pharmaceutical companies don’t have to publicly disclose plans to raise drug prices, according to information CalPERS’ legal office is presenting to its Board of Administration this week."
When companies filed the notices last fall Reuters requested the filings from CalPERS and California Correctional Health Care Services under the state’s public records law. Both CalPERS and CCHCS informed the drug makers that they planned to release the records. Amgen, Ipsen Biopharmaceuticals and GlaxoSmithKline then sued the agencies to keep the information private.
According to the article, the pharmaceutical industry is still arguing that the 2017 law is unconstitutional. A district court judge dismissed the Pharmaceutical Research and Manufacturers of America’s challenge to the law last year, and the organization filed an amended complaint in September.